The flowchart in Figure 1 summarizes the selection procedure of patients and control subjects in the study. Of the patients with COPD, 5.5% were excluded because depression had been diagnosed ...

Chronic lower respiratory diseases, namely, asthma and chronic obstructive pulmonary disease (COPD), are the fifth-leading cause of death in the United States. A contributing factor is diagnostic ...

When spirometry is unavailable, physicians can use the St. George’s Respiratory Questionnaire score plus peak expiratory flow to screen for COPD, according to data published in American Journal ...

Self-administered high-flow therapy for COPD and type 1 respiratory failure: benefit not proven Due to a lack of meaningful study data, no benefit can be derived. As the legal requirements for a ...

A new study tested the theory that, for patients with an exacerbation of COPD combined with hypercapnia, high-flow nasal therapy (HFNT) would be the right treatment at the right time.